GCTK
NASDAQ HealthcareGlucoTrack, Inc. - Common Stock
Medical Devices
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
๐ Market Data
| Price | $0.34 |
|---|---|
| Volume | 22,618,127 |
| Market Cap | 2.64M |
| Beta | 0.660 |
| RSI (14-Day) | 51.6 |
| 200-Day MA | $2.10 |
| 50-Day MA | $0.41 |
| 52-Week High | $14.14 |
| 52-Week Low | $0.25 |
| P/E Ratio | 0.05 |
| Price / Book | -1.01 |
๐ฏ Investment Strategy Scores
GCTK scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (99/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Moon Shot (37/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find GCTK in your text
Paste any article, transcript, or post โ the tool will extract GCTK and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.